The pathological and clinical landscape of refractory metastatic triple negative breast cancer: a narrative review.

Jiang, Meng-Ping; Huang, Xiang; Yin, Yong-Mei; Tang, Jin-Hai

Jiang, Meng-Ping; Huang, Xiang; Yin, Yong-Mei; Tang, Jin-Hai.

Afiliación

Jiang MP; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Huang X; The First Clinical College of Nanjing Medical University, Nanjing, China.
Yin YM; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Tang JH; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Ann Transl Med ; 10(16): 907, 2022 Aug.

Article en En | MEDLINE | ID: mdl-36111045

Palabras clave

Refractory metastatic triple negative breast cancer; antibody-drug conjugate (ADC); chemotherapy; immunotherapy; prognostic factors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Aspecto: Patient_preference Idioma: En Revista: Ann Transl Med Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google